UK markets close in 2 hours 26 minutes

Pfizer Inc. (PFE)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
51.78+1.54 (+3.07%)
At close: 04:03PM EST
51.49 -0.29 (-0.56%)
Pre-market: 09:03AM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
99,878,000
81,288,000
41,908,000
51,750,000
53,647,000
Cost of revenue
34,432,000
30,821,000
8,692,000
10,219,000
11,248,000
Gross profit
65,446,000
50,467,000
33,216,000
41,531,000
42,399,000
Operating expenses
Research development
14,728,000
13,829,000
9,405,000
8,650,000
8,006,000
Selling general and administrative
13,136,000
12,703,000
11,615,000
14,350,000
14,455,000
Total operating expenses
31,299,000
30,232,000
24,456,000
27,610,000
27,354,000
Operating income or loss
34,147,000
20,235,000
8,760,000
13,921,000
15,045,000
Interest expense
1,241,000
1,291,000
1,449,000
1,574,000
1,316,000
Total other income/expenses net
288,000
5,331,000
113,000
5,108,000
-2,178,000
Income before tax
33,325,000
24,311,000
7,497,000
17,682,000
11,885,000
Income tax expense
3,347,000
1,852,000
477,000
1,384,000
706,000
Income from continuing operations
29,978,000
22,459,000
7,021,000
16,298,000
11,179,000
Net income
29,771,000
21,979,000
9,616,000
16,273,000
11,153,000
Net income available to common shareholders
29,771,000
21,979,000
9,616,000
16,272,000
11,152,000
Basic EPS
-
3.92
1.73
2.92
1.90
Diluted EPS
-
3.85
1.71
2.87
1.87
Basic average shares
-
5,601,000
5,555,000
5,569,000
5,872,000
Diluted average shares
-
5,708,000
5,632,000
5,675,000
5,977,000
EBITDA
-
30,793,000
13,723,000
25,266,000
19,585,000